ADR120S, Inc. (TYO:3750)
Japan · Delayed Price · Currency is JPY 811.00
-1.00 (-0.12%)
May 12, 2026, 3:30 PM JST
ADR120S Market Cap
ADR120S has a market cap or net worth of 7.25 billion as of May 12, 2026. Its market cap has increased by 18.54% in one year.
Market Cap
7.25B
Enterprise Value
7.40B
Revenue
40.00M
Ranking
n/a
PE Ratio
n/a
Stock Price
811.00
Market Cap Chart
Since June 28, 2006, ADR120S's market cap has decreased from 8.22B to 7.25B, a decrease of -11.79%. That is a compound annual growth rate of -0.63%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| May 11, 2026 | 7.25B | -3.33% |
| Dec 30, 2025 | 7.50B | -2.89% |
| Dec 30, 2024 | 7.72B | -24.06% |
| Dec 29, 2023 | 10.17B | -6.18% |
| Dec 30, 2022 | 10.84B | -4.64% |
| Dec 30, 2021 | 11.37B | -10.32% |
| Dec 30, 2020 | Upgrade Pro | Upgrade Pro |
| Dec 30, 2019 | Upgrade Pro | Upgrade Pro |
| Dec 28, 2018 | Upgrade Pro | Upgrade Pro |
| Dec 29, 2017 | Upgrade Pro | Upgrade Pro |
| Dec 30, 2016 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| MEDINET | 7.71B |
| Carna Biosciences | 7.64B |
| BrightPath Biotherapeutics | 7.57B |
| Kohjin Bio | 7.57B |
| StemCell Institute | 7.56B |
| CellSource | 7.18B |
| Chiome Bioscience | 7.02B |
| TMS Co., Ltd. | 6.87B |